semaglutide and heart Cuts Risk Beyond Weight Loss: Study Semaglutide Benefits Diabetic Patients Regardless

In STEP 1, GI side effects affected 74.2 percent of semaglutide users versus 47.9 percent on placebo [1]

In addition, long-term use of GLP-1RAs may also have potential safety risks, such as pancreatitis (Shetty et al., 2022) and thyroid diseases ( 6 Discussion T2DM is a chronic disease characterized by hyperglycemia, which eventually leads to microvascular damage and macrovascular events, as well as complications related to peripheral vascular diseases

These include: Fatigue, weakness, and pallor are the most common symptoms that appear in the early stages

Zepbound has since also received approval for obstructive sleep apnea in adults with obesity, expanding its clinical applications

Her vital signs were 190/100 mmHg, 115 beats/min, 24 breaths/min, and 36 body temperature